Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Taking a bite out of Charcot-Marie-Tooth Disease

    ... suffers from a rare and often severe subtype of CMT called type 1E, caused by mutations in a gene that codes for peripheral myelin ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  2. Applications now open for ASPIRE postdoctoral research fellowship to support path to entrepreneurship

    ... to Innovate Postdoctoral Fellowship , which begins July 1, 2024, through the Office of Biomedical Research Education and Training ... structured training opportunity to learn how to transform a technology into a company A biomedical sciences postdoc will be hired to ...

    sommers - 02/07/2024 - 10:47am

  3. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.   ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  4. Scn1a Knockout Mouse Genetic Model of Epilepsy

    ... in Dravet syndrome mice. Neurobiol Dis. 65:1-11. Project ID:  MKT15070 ... Tools Research Tool Type: Animal Model Featured:  ...

    cttc_admin - 05/31/2023 - 2:08pm

  5. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ... Oncology Research Tool Type: Cellular Therapy ...

    cttc_admin - 01/18/2024 - 9:10am

  6. Vanderbilt scientists, research translation experts attend CMT Global Research Convention

    ... conference,  Margaret Read , Vanderbilt’s  Center for Technology Transfer and Commercialization  general manager for corporate ... primary genetic cause of CMT in patients with CMT disease type 1A. Sanders and Carter are co-primary investigators on the project. In ...

    sommers - 10/02/2023 - 11:32am

  7. Vanderbilt launches Innovation Catalyst Fund to propel translational research and innovation

    ... Cybele Raver and Vice Chancellor for Finance and Information Technology Brett Sweet. The program is aimed at moving translational research ... the inaugural cycle of proposal submissions on Sunday, Oct. 1; proposals will be due by Tuesday, Oct. 31. Application cycles in 2024 will ...

    sommers - 09/12/2023 - 9:41am

  8. Vanderbilt generates more than $96M in licensing revenue in FY23, most in university history

    ... 08/09/2023 The Vanderbilt  Center for Technology Transfer and Commercialization  raked in $96 million in licensing ... University Medical Center, in FY23 CTTC completed more than 1,100 material transfer agreements; reviewed more than 160 industry funding and ...

    sommers - 08/09/2023 - 2:32pm

  9. Wolbachia genetic tools for population control of harmful insects

    ... that facilitates insect range expansion.   Technology Overview Vanderbilt researchers have developed several ... . Unlike methods currently in the market that employ wild-type Wolbachia , which does not survive in higher temperatures and loses ...

    cttc_admin - 02/15/2024 - 1:30pm

  10. Continuum Robots with Equilibrium Modulation (CREM)

    ... in surgical contexts. The present continuum robot technology’s novel method of equilibrium modulation can be used for both ... biopsy, and micro-scale intervention.  Figure 1. Image (a) A parallel robot using CREM (b) A continuum snake-like robot using ...

    cttc_admin - 02/14/2024 - 8:48am